Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | MAPT | P10636 | 5/20 | 0.39 |
| ▸ | GAA | P10253 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | PPARG | P37231 | 2/20 | 0.39 |
| ▸ | PPARD | Q03181 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.39 |
| ▸ | CNR1 | P21554 | 2/20 | 0.39 |
| ▸ | CNR2 | P34972 | 2/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.39 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.39 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | PPARA | Q07869 | 1/20 | 0.36 |
| ▸ | TNKS | O95271 | 2/20 | 0.36 |
| ▸ | PARP1 | P09874 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9301795 | 0.82 | GABRA1 (0.35) | XDHALDH1A1MAPTGAAMEN1 | |
| SCHEMBL9346680 | 0.78 | IMPDH2 (0.33) | XDHNPSR1 | |
| SCHEMBL215399 | 0.78 | XDH (0.50) | XDHALDH1A1MAPTGAAMEN1 | |
| SCHEMBL14877309 | 0.76 | PTGS2 (0.44) | MEN1KMT2ACNR1CNR2CYP3A4 | |
| SCHEMBL2556929 | 0.75 | XDH (0.45) | XDHALDH1A1MAPTGAAMEN1 | |
| SCHEMBL10339189 | 0.73 | XDH (0.39) | XDHALDH1A1MAPTGAAMEN1 | |
| SCHEMBL22469881 | 0.73 | XDH (0.39) | XDHALDH1A1MAPTGAAMEN1 | |
| SCHEMBL10582024 | 0.73 | IMPDH2 (0.33) | XDHNPSR1 | |
| SCHEMBL9403340 | 0.73 | PDE4A (0.36) | GABRA1GABRB2PDE4APDE4CPDE4D | |
| SCHEMBL11458793 | 0.73 | DCTPP1 (0.31) | GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080200648-A1 | Avoids undesired epimerisation of alpha-carbon of C-terminal amino acid; acidolysis | LONZA AG (CH) | 2008-08-21 | — | — | US | claimed |
| EP-1771463-B1 | METHOD OF PEPTIDE SYNTHESIS | LONZA AG (CH) | 2008-01-02 | — | — | EP | claimed |
| EP-1771463-A1 | METHOD OF PEPTIDE SYNTHESIS | LONZA AG (CH) | 2007-04-11 | — | — | EP | claimed |
| WO-2006008050-A1 | METHOD OF PEPTIDE SYNTHESIS | LONZA AG (CH) | 2006-01-26 | — | — | WO | claimed |
| EP-0104984-B1 | VINYLCARBAMIC ACID ESTERS AND THEIR PREPARATION | SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) | 1990-05-16 | — | — | EP | claimed |
| EP-0104984-A2 | Vinylcarbamic acid esters and their preparation | SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) | 1984-04-04 | — | — | EP | claimed |
| CN-120152714-A | Anti-inflammatory compounds, pharmaceutical compositions, and methods of treating hemochromatosis and other diseases | 米拉洛克斯有限责任公司 | 2025-06-13 | — | — | CN | disclosed |
| EP-3414257-B1 | METHOD FOR PREPARATION OF LIRAGLUTIDE USING BAL LINKER | POLYPEPTIDE LABORATORIES HOLDING PPL AB (SE) | 2023-06-07 | — | — | EP | disclosed |
| EP-3405476-B1 | METHOD FOR PREPARATION OF PEPTIDES WITH psWANG LINKER | POLYPEPTIDE LABORATORIES HOLDING PPL AB (SE) | 2022-05-18 | — | — | EP | disclosed |
| US-11236123-B2 | Method for preparation of peptides with psWang linker | POLYPEPTIDE LABORATORIES HOLDING (PPL) AB (SE) | 2022-02-01 | — | — | US | disclosed |
| US-11174298-B2 | Preparation and use of ginsentides and ginsentide-like peptides | Tam, James P. (SG) | 2021-11-16 | — | — | US | disclosed |
| US-20210155665-A1 | METHOD FOR PREPARING INTERLEUKIN-2 OR INTERLEUKIN-2 ANALOGUES | ETH ZURICH (CH) | 2021-05-27 | — | — | US | disclosed |
| US-20200277343-A1 | PREPARATION AND USE OF GINSENTIDES AND GINSENTIDE-LIKE PEPTIDES | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2020-09-03 | — | — | US | disclosed |
| WO-2006048144-A1 | CYCLIZATION OF A PEPTIDE | LONZA AG (CH) | 2006-05-11 | — | — | WO | disclosed |
| WO-2006045603-A1 | S-ALKYL-SULPHENYL PROTECTION GROUPS IN SOLID-PHASE SYNTHESIS | LONZA AG (CH) | 2006-05-04 | — | — | WO | disclosed |
| WO-2006045483-A2 | ON-RESIN PEPTIDE CYCLIZATION | LONZA AG (CH) | 2006-05-04 | — | — | WO | disclosed |
| WO-2006032457-A1 | PEPTIDE CYCLISATION | LONZA AG (CH) | 2006-03-30 | — | — | WO | disclosed |
| WO-2006008050-A1 | METHOD OF PEPTIDE SYNTHESIS | LONZA AG (CH) | 2006-01-26 | — | — | WO | disclosed |
| US-5026933-A | Mixture of mono-olefins, alkylation, sulfonation | MOBIL OIL CORPORATION (US) | 1991-06-25 | — | — | US | disclosed |
| US-4870038-A | NEUTRALIZED WITH 2,4,6-COLLIDINE; LINEAR OLIGOMERS | MOBIL OIL CORPORATION (US) | 1989-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11174298-B2 | Preparation and use of ginsentides and ginsentide-like peptides | NPR1, RXFP1, NPR3 | XDH 3620/4885ALDH1A1 2760/4885MAPT 4866/4885 |
| US-20080200648-A1 | Avoids undesired epimerisation of alpha-carbon of C-terminal amino acid; acidolysis | NGLY1, PTMS, ANPEP | XDH 4360/4885ALDH1A1 4354/4885MAPT 4139/4885 |
| US-20200277343-A1 | PREPARATION AND USE OF GINSENTIDES AND GINSENTIDE-LIKE PEPTIDES | NPR1, RXFP1, NPR3 | XDH 3620/4885ALDH1A1 2760/4885MAPT 4866/4885 |
| US-11236123-B2 | Method for preparation of peptides with psWang linker | VIP, GLP1R, IAPP | XDH 4768/4885ALDH1A1 4859/4885MAPT 3425/4885 |
| US-20210155665-A1 | METHOD FOR PREPARING INTERLEUKIN-2 OR INTERLEUKIN-2 ANALOGUES | IL2, IL2RA, IL1A | XDH 4706/4885ALDH1A1 2061/4885MAPT 3027/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.